This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: The Innovative Mind of Katja Montan: Pioneering Multispecific Antibody Analysis
Introduction: Katja Montan, an accomplished inventor based in Munich, Germany, has made significant strides in the field of biotechnology. With a focus on multispecific antibodies, her work is paving the way for advancements in medical diagnostics and therapies.
Latest Patents: Katja Montan holds a patent titled "Method for detecting multispecific antibody light chain mispairing." This innovative technique involves the use of limited digestion with a proteolytic enzyme to analyze the light chain pairing of multispecific antibodies. Her patent showcases her contribution to improving the accuracy of antibody analysis, which is crucial for developing targeted treatments.
Career Highlights: Currently affiliated with Hoffmann-La Roche Inc., Katja has demonstrated her expertise in pharmaceutical research and development. Her role involves leveraging her knowledge of biochemistry and immunology to enhance the efficiency of antibody-based therapies.
Collaborations: Throughout her career, Katja has collaborated with esteemed colleagues, including Michael Molhoj and Maximiliane Koenig. These partnerships highlight her commitment to teamwork and innovation, contributing to the advancement of their shared objectives in the biotech field.
Conclusion: Katja Montan stands out as a notable inventor in the realm of biotechnology. With her patent focusing on multispecific antibodies, she is not only enhancing diagnostic capabilities but also solidifying her place as a leading figure in her field. Her ongoing work at Hoffmann-La Roche Inc. and collaborations with talented coworkers further underline her dedication to innovation and scientific advancement.